BIO’s investment into Centre médical de la Communauté’s operations in the Democratic Republic of the Congo for EUR 2.7 million

Lead party: Belgian Investment Company for Developing Countries (BIO) (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Centre médical de la Communauté (private company) · Sector: Healthcare, Specialty Healthcare Providers, Primary Care Providers · Countries of operation: Democratic Republic of the Congo (DRC) Transaction type: Debt Financing ·…


Lead party: Belgian Investment Company for Developing Countries (BIO) (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Centre médical de la Communauté (private company) · Sector: Healthcare, Specialty Healthcare Providers, Primary Care Providers · Countries of operation: Democratic Republic of the Congo (DRC)

Transaction type: Debt Financing · Asset class: Private Credit · Strategy: Direct Lending · Instrument: Debt · Deal amount: US$3.1m

Lead investor/buyer: Belgian Investment Company for Developing Countries (BIO) · Investors/buyers: Belgian Investment Company for Developing Countries (BIO)

Legal advisers: not identified in the source record.

Source: announced 9 May 2016. Original announcement: bio-invest.be.